MASI Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 1314 min ago

@ $130.38

Išleistas: 28 birž. 2024 @ 16:30

Grąža: -3.41%

Ankstesnis signalas: birž. 26 - 22:30

Ankstesnis signalas: Pardavimas

Grąža: -0.52 %

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.06% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	856 279
Vidutinė apimtis	656 011
Rinkos kapitalizacija	6.70B
EPS	$0.360 ( Q1 \| 2024-05-07 )
Kita pelno data	( $0.770 ) 2024-08-13
Last Dividend	$1.000 ( 2012-11-23 )
Next Dividend	$0 ( N/A )
P/E	85.67 (Sector) 42.63 (Industry) 0
ATR14	$7.22 (5.73%)

AKYA -4.10%

ANGO 2.02%

APR 0.00%

ATRC -2.23%

ATRI -0.16%

ATRS 0.18%

AVGR -3.13%

AZTA 1.00%

BLFS 4.54%

EKSO 0.48%

FEMY -0.87%

GMVD 1.38%

HBIO -1.72%

HOLX 0.05%

ICUI 0.03%

IIN 0.12%

ISRG -0.06%

KRMD -7.02%

LMAT 0.00%

LMNX 0.00%

MASI -4.23%

MBOT -0.97%

MHUA -2.27%

MMSI 3.01%

NEPH 0.96%

NSTG -37.43%

NVCR -2.84%

NXGL -0.69%

OSUR 0.95%

PDEX 3.92%

PLSE 1.63%

POAI 0.00%

QDEL -0.92%

RGEN -0.42%

SDC -53.45%

SMTI -2.99%

STAA 1.80%

STSS 0.21%

UTMD -0.06%

XRAY -0.88%

ZTEK 4.90%

Insider Trading

Date	Person	Action	Amount	type
2024-06-26	Reynolds Craig B	Buy	1 228	Common Stock
2024-06-26	Reynolds Craig B	Sell	1 228	Restricted Stock Units
2024-05-01	Reynolds Craig B	Buy	10 000	Common Stock
2024-05-01	Reynolds Craig B	Sell	10 000	Non-Qualified Stock Option (Right to Buy)
2024-04-26	Reynolds Craig B	Buy	40 000	Common Stock

INSIDER POWER
50.63
Last 94 transactions
Buy: 724 214 \| Sell: 238 867

Koreliacija (AI algo v.1.1b): Undervalued: 0.06% $126.06 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.55 (weak negative)

Trumpas: 0.84 (strong)

Signal:(65) Same movement expected

Masimo Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ALRN	0.857
MAR	0.806

10 Labiausiai neigiamai susiję koreliacijos
OM	-0.862
PLTK	-0.827
PLXS	-0.826
CSSEP	-0.824
ALHC	-0.822
LFUS	-0.816
KOSS	-0.808
SNAX	-0.807

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Masimo Corp Koreliacija - Valiuta/Žaliavos

0.71
( moderate )

-0.17
( neutral )

0.00
( neutral )

-0.05
( neutral )

0.66
( moderate )

-0.72
( moderate negative )

Masimo Corp Finansinės ataskaitos

Annual	2023
Pajamos:	$2.05B
Bruto pelnas:	$1.00B (49.00 %)
EPS:	$1.540

FY	2023
Pajamos:	$2.05B
Bruto pelnas:	$1.00B (49.00 %)
EPS:	$1.540

FY	2022
Pajamos:	$2.04B
Bruto pelnas:	$1.06B (52.01 %)
EPS:	$2.68

FY	2021
Pajamos:	$1.24B
Bruto pelnas:	$808.35M (65.23 %)
EPS:	$4.16

Financial Reports:

No articles found.

Masimo Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Masimo Corp Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.40 - good (93.98%) | Divividend Growth Potential Score: 3.01 - No dividend growth expected in the near future

Information

First Dividend	$2.00	2010-03-09
Last Dividend	$1.000	2012-11-23
Next Dividend	$0	N/A
Payout Date	2012-12-11
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	$3.75	--
Avg. Dividend % Per Year	0.00%	--
Score	2.09	--
Div. Sustainability Score	9.40
Div.Growth Potential Score	3.01
Div. Directional Score	6.21	--

Next Divdend (Est)
(2025-01-16)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

2.09

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2010	$2.75	9.24%
2011	$0	0.00%
2012	$1.000	5.31%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
23 Nov 2012	$1.000	01 Nov 2012	27 Nov 2012	11 Dec 2012
03 Dec 2010	$0.750	22 Nov 2010	07 Dec 2010	21 Dec 2010
09 Mar 2010	$2.00	22 Feb 2010	11 Mar 2010	31 Mar 2010

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0400	1.500	9.20	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0267	1.200	9.11	10.00	[0 - 0.3]
returnOnEquityTTM	0.0595	1.500	-0.450	-0.674	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.31	0.800	3.44	2.75	[1 - 3]
quickRatioTTM	1.092	0.800	8.28	6.63	[0.8 - 2.5]
cashRatioTTM	0.297	1.500	9.46	10.00	[0.2 - 2]
debtRatioTTM	0.323	-1.500	4.61	-6.91	[0 - 0.6]
interestCoverageTTM	3.04	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	2.63	2.00	9.12	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.966	2.00	9.52	10.00	[0 - 20]
debtEquityRatioTTM	0.701	-1.500	7.20	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.486	1.000	5.23	5.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.0776	1.000	-0.447	-0.447	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.146	1.000	-0.301	-0.301	[0.2 - 2]
assetTurnoverTTM	0.668	0.800	8.88	7.10	[0.5 - 2]
Total Score				9.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	84.38	1.000	1.577	0	[1 - 100]
returnOnEquityTTM	0.0595	2.50	-0.289	-0.674	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.966	2.00	9.68	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.63	2.00	9.12	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.55	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0706	1.000	-0.735	0	[0.1 - 0.5]
Total Score				3.01

Masimo Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Masimo Corp

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.